Bristol-Myers Squibb to Take Part in Deutsche Bank Annual Health Care Conference

NEW YORK--()--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the 42nd Annual Deutsche Bank Health Care Conference on Thursday, May 4, 2017, in Boston. Charles Bancroft executive vice president, head of Global Business Operations, will answer questions about the company at 11:20 a.m. EDT.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, and YouTube.

Contacts

Bristol-Myers Squibb Company
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Tim Power 609-252-7509
timothy.power@bms.com
or
Bill Szablewski, 609-252-5894
william.szablewski@bms.com

Release Summary

Bristol-Myers Squibb to Take Part in Deutsche Bank Annual Health Care Conference

$Cashtags

Contacts

Bristol-Myers Squibb Company
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Tim Power 609-252-7509
timothy.power@bms.com
or
Bill Szablewski, 609-252-5894
william.szablewski@bms.com